- Home
- XPRO vs CERT Comparison
XPRO vs CERT Comparison
Compare XPRO & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XPRO | CERT |
|---|---|---|
| Founded | 1938 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.2B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XPRO | CERT |
|---|---|---|
| Price | $15.92 | $6.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $15.25 | $12.22 |
| AVG Volume (30 Days) | 1.1M | ★ 3.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $522,493,000.00 | $418,838,000.00 |
| Revenue This Year | $6.71 | $5.05 |
| Revenue Next Year | $2.10 | $5.73 |
| P/E Ratio | $37.71 | ★ N/A |
| Revenue Growth | ★ 14.89 | 8.75 |
| 52 Week Low | $6.70 | $6.04 |
| 52 Week High | $18.73 | $15.38 |
Technical Indicators
Market Signals| Indicator | XPRO | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 43.38 | 30.51 |
| Support Level | $15.23 | $6.04 |
| Resistance Level | $16.95 | $7.52 |
| Average True Range (ATR) | 0.85 | 0.41 |
| MACD | -0.18 | 0.05 |
| Stochastic Oscillator | 8.77 | 23.31 |
Price Performance
Historical ComparisonAbout XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA); and Asia-Pacific (APAC). The majority of its revenue is derived from the North and Latin America (NLA) segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.